Surgical Science Sweden AB (publ) (SUSRF) Q1 2026 Earnings Call Transcript
Surgical Science Sweden AB (publ) reported its Q1 2026 earnings, revealing a 6% decline in sales to SEK 236 million. The company attributed part of this decline to currency headwinds affecting their financial results. CEO Tom Englund and CFO Anna Ahlberg discussed the quarter's performance and opened the floor for questions during the earnings call.
- ▪Surgical Science Sweden AB's reported sales for Q1 2026 were SEK 236 million, down 6% from the previous year.
- ▪The decline in sales was partially attributed to currency headwinds.
- ▪CEO Tom Englund and CFO Anna Ahlberg led the earnings call, discussing the company's performance.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4907218-surgical-science-sweden-ab-publ-susrf-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
